We develop, manufacture and commercialise a comprehensive range of critical care products for patients all around the world.
These medicines are used for the specialised care of patients whose condition are life-threatening and require comprehensive care and monitoring.
38 million people in Europe are admitted each year in emergency care units at hospitals
The 5 primary critical care admission diagnoses for adults*
* Source – Society of Critical Care Medicine
Our broad range of products play a key role in emergency situations
We have a broad range of injectable drugs meant for life-threatening emergencies that require immediate and fast intervention, such as a heart attack, convulsions and hypotension or/and as well in case of poisoning.
These medicines are typically administered at hospital by anaesthesiologists, surgeons or specialists in internal medicine, in theatre, intensive care or high dependency units.
First responders also administer these medicines on the field, in emergency trucks for example.
Our Critical Care products are part of the WHO recommendation list of essential medicines. We serve governmental and no governmental organisations such as MEG (Medical Export Group), IDA Foundation and MSF (Médecins sans Frontières) all around the world.
Our large range of products assist *NGO’s in everyday disaster situations
*NGO – Non Governmental Organisation
We manufacture and commercialise an in-house comprehensive range of glass ampoules addressing the principle issues in essential and emergency medicines; cardiac function and blood pressure, pain and metabolic homeostasis as well as differentiated products for specific uses such as apnoea of prematurity, emergency ENT (ear, nose and throat) surgery and paracetamol overdose.
We operate principally in the UK and the Middle East where we have a successful track-record and our critical care ampoules are widely used at hospitals in all units.
As of today, we have more than 50 different presentations of glass ampoules and hold more than 120 Marketing Authorizations
We also develop manufacture and commercialise Pre-Filled Syringes (PFS) used principally for the emergency treatment of cardiac arrest.
PFS offer significant benefits over the traditional ??vial and syringe?? format, by increasing dosing accuracy, safety and convenience. The usage of PFS in Critical Care is increasing at hospitals and in ambulances for many reasons such as
- Avoiding mistakes during administration
- Providing fast medication
- Risk reduction related to preparation drug
- Economic interest comparing waste of syringe prepared
- Nursing time saving
Our Range of Pre-Filled Syringes comprises 9 products and has been designed to enhance ease of use and help improve patient safety in case of cardiopulmonary resuscitation or in the operating theatre environment.
The one-piece, critical care glass syringe that is pre-filled
and ready to use in a twist: